Clinical Trial Update: Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating interleukin-2 in children who have undergone bone marrow transplantation for acute myeloid leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 1 | Status: COMPLETED